Status:
COMPLETED
Female Sexual Dysfunction Intervention
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Sexual Dysfunction
Eligibility:
FEMALE
18+ years
Brief Summary
The goal of this psychosocial research study is to learn whether a website program called "Tendrils: Sexual Renewal for Women after Cancer " may help female cancer survivors improve their sex lives wh...
Detailed Description
The Tendrils website is designed to give women information about sexual problems related to cancer and its treatment, and the website suggests ways to overcome those problems. The website can be viewe...
Eligibility Criteria
Inclusion
- Phase I: Woman cancer survivor
- Phase I: Speaks and reads English well enough to evaluate the website and participate in a focus group
- Phase II: Had breast cancer or a gynecological cancer diagnosed 1 to 5 years previously
- Phase II: Has a sexual partner in relationship of at least 6 months' duration.
- Phase II: Has a score on the Female Sexual Function Inventory below the cut-off criterion indicating sexual dysfunction (i.e. less than 26.55 total score).
- Phase II: Lives in commuting distance of MDACC so that can attend 3 counseling sessions if randomized to professional treatment group.
- Phase II: Currently no evidence of active cancer.
- Phase II: Not receiving any cancer treatment other than hormonal therapy.
Exclusion
- Phase I: Under age 18
- Phase II: Under age 18
- Phase II: Currently in mental health care for a sexual problem.
- Phase II: BSI-18 at study entry indicates high distress and a visit with project staff confirms that the participant is too distressed to benefit safely from the intervention.
- Phase II: Cannot arrange for participant to have privacy when accessing internet at home, even if we offer loaner laptop and subsidized internet service.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT00614276
Start Date
October 1 2007
End Date
August 1 2013
Last Update
January 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030